Nano crystalline silver: a breakthrough in treating diabetic foot ulcers


  • Vishal Kaundal Department of Surgery, Zonal Hospital Dharamshala, Himachal Pradesh, India
  • Vikrant Sharma Department of Surgery, Zonal Hospital Dharamshala, Himachal Pradesh, India



Nano crystalline silver, Diabetic foot, Non-healing ulcers, Peripheral arterial disease, HbA1C


India harbours world’s largest population of diabetic patients thus earning an infamous designation of ‘diabetic capital of the world’. Apart from various metabolic aberrations that are bound to happen in a patient with uncontrolled hyperglycemia, foot ulcers are one of the serious complications that may become limb and life threatening, if not addressed properly. Surgical debridement along with appropriate antibiotics, remain as the mainstay of management of such wounds. Conventional dressing methods involving povidone-iodine and other antiseptic agents have offered limited scope of effective wound healing owing to their inherent toxicity towards fibroblasts. In the present scenario where a large chunk of population crosses over to the list of newly diagnosed diabetics every year, nano crystalline silver has come as a breakthrough in effective management and early healing of diabetic foot ulcers through its effective antimicrobial action and limited toxicity for the host tissue.


Mohan V, Sandeep S, Deepa R, Shah B, Vargheese C. Epidemiology of type II diabetes mellitus: Indian scenario. Indian J Med Res. 2007;125(3):217-30.

Sicree R, Shaw J, Zimnet P, Tapp R. The global burden of diabetes. Diabetes Atlas. 2003;3:15-73.

Parving H, Hommel E, Mathiesen E, Skott P, Edsberg B, Bahnsen M, et al. Prevalance of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes mellitus. BMJ. 1988;296(1):156-60.

Abbot CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The North West diabetes foot care study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabetes UK. Diabetic Med. 2002;19:377-84.

Boulton AJM, Armstrong DG, Albert SF, Fryberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment. Diabetes Care. 2008;31(11):1679-85.

Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217-28.

Boulton AJ, Kirsner RS, Vileikyte L. Clinical practice: neuropathic diabetic ulcers. N Engl J Med. 2004;351:40-55.

Dowsett C. The use of silver-based dressings in wound care. Nursing Standard. 2004;19(7):56-60.

Russell AD, Hugo WB. Antimicrobial activity and action of silver. Progress in Medical Chemistry 1994;31:351-71.

Calhoun JH, Eng M, Cantrell J, Cobose J, Lacy J, Valdez RR, et al. Treatment of diabetic foot infections: wagner classification, therapy, and outcome. Foot and Ankle. 1988;9(3):101-6.

Sharma R, Gupta N, Kumar V, Pal S, Sharma R, Kaundal V, et al. Silver colloid dressings score over conventional dressings in diabetic foot ulcer: a randomized clinical trial. Int Surg J. 2017;4(8):2627-31.






Case Reports